CLINICAL TRIALS

Open Access
Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study
Graeme Jones, Thomas Wallace, Matthew J. McIntosh, Laura Brockwell, Juan J. Gómez-Reino and Anthony Sebba

The Journal of Rheumatology February 1 2017, 44 (2) 142-146; DOI: https://doi.org/10.3899/jrheum.160287
You have access
Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop
Jason W. Busse, Susan J. Bartlett, Maxime Dougados, Bradley C. Johnston, Gordon H. Guyatt, John R. Kirwan, Kent Kwoh, Lara J. Maxwell, Andrew Moore, Jasvinder A. Singh, Randall Stevens, Vibeke Strand, Maria E. Suarez-Almazor, Peter Tugwell and George A. Wells

The Journal of Rheumatology October 1 2015, 42 (10) 1962-1970; DOI: https://doi.org/10.3899/jrheum.141440
You have access
Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman

The Journal of Rheumatology August 1 2015, 42 (8) 1392-1400; DOI: https://doi.org/10.3899/jrheum.141650
You have access
Clinical Trials Perception in Rheumatology Patients: Experience from a Single Rheumatology Tertiary Center
Coziana Ciurtin, Maria Leandro, Halina Fitz-Clarence, Hanh Nguyen, Stephen B. Walsh and David A. Isenberg

The Journal of Rheumatology June 1 2015, 42 (6) 988-993; DOI: https://doi.org/10.3899/jrheum.141091
You have access
Immunosuppressive Therapies for the Induction Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman

The Journal of Rheumatology October 1 2014, 41 (10) 1998-2007; DOI: https://doi.org/10.3899/jrheum.140050
You have access
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
Maarten Boers, John R. Kirwan, Laure Gossec, Philip G. Conaghan, Maria-Antonietta D’Agostino, Clifton O. Bingham III, Peter M. Brooks, Robert Landewé, Lyn March, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 1025-1030; DOI: https://doi.org/10.3899/jrheum.131314
You have access
Updating the OMERACT Filter at OMERACT 11
John R. Kirwan, Maarten Boers and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 975-977; DOI: https://doi.org/10.3899/jrheum.131306
You have access
Toward a Generalized Framework of Core Measurement Areas in Clinical Trials: A Position Paper for OMERACT 11
Maarten Boers, Leanne Idzerda, John R. Kirwan, Dorcas Beaton, Reuben Escorpizo, Annelies Boonen, Susan Magasi, Ian Sinha, Gerold Stucki and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 978-985; DOI: https://doi.org/10.3899/jrheum.131307
You have access
Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
Leanne Idzerda, Tamara Rader, Peter Tugwell and Maarten Boers

The Journal of Rheumatology May 1 2014, 41 (5) 986-993; DOI: https://doi.org/10.3899/jrheum.131308
You have access
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 994-999; DOI: https://doi.org/10.3899/jrheum.131309

Main menu

User menu

Search

CLINICAL TRIALS

Pages

Content

Resources

Subscribers

More